Caren Deardorf - 11 Mar 2022 Form 3 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Role
Director
Signature
/s/Marc Wilson, as attorney-in-fact
Issuer symbol
CRNX
Transactions as of
11 Mar 2022
Net transactions value
$0
Form type
3
Filing time
14 Mar 2022, 17:18:56 UTC
Previous filing
17 Feb 2022
Next filing
19 May 2022

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power-of-Attorney